VP 16-213 IN ACUTE MYELOGENOUS LEUKEMIA

被引：51
|
作者：
SMITH, IE
GERKEN, ME
CLINK, HM
MCELWAIN, TJ
机构：
[1] INST CANC RES,LEUKAEMIA UNIT,SUTTON,ENGLAND
[2] ROY MARSDEN HOSP,SUTTON,SURREY,ENGLAND
来源：
POSTGRADUATE MEDICAL JOURNAL | 1976年 / 52卷 / 604期
关键词：
D O I：
10.1136/pgmj.52.604.66
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 70
页数：5
相关论文
共 50 条
  • [41] DISSIMILAR EFFECTS ON THYMIDINE INCORPORATION AND DNA-SYNTHESIS OF PODOPHYLLOTOXIN DERIVATIVE VP 16-213
    GRIEDER, A
    MAURER, R
    STAHELIN, H
    EXPERIENTIA, 1973, 29 (06): : 772 - 772
  • [42] MONO AND COMBINATION CHEMOTHERAPY WITH VP 16-213 IN SMALL CELL LUNG-CANCER (SLC)
    BRUNNER, K
    JUNGI, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 308 - 308
  • [43] HPLC ANALYSIS OF THE ANTI-NEOPLASTIC AGENTS VP-16-213 AND VM-26 BY UV AND ELECTROCHEMICAL DETECTION - ANALYSIS OF THE METABOLITES OF VP 16-213 IN URINE
    HOLTHUIS, JJM
    SIJSTERMANS, AW
    ROMKENS, FMGM
    WELLER, EBCM
    VANOORT, WJ
    PINEDO, HM
    MCVIE, JG
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1982, 4 (06) : 199 - 199
  • [44] ACTIVITY OF A NEW GLYCOSIDIC LIGNAN DERIVATIVE (VP 16-213) RELATED TO PODOPHYLLOTOXIN IN EXPERIMENTAL TUMORS
    STAHELIN, H
    EUROPEAN JOURNAL OF CANCER, 1973, 9 (03) : 215 - 221
  • [45] SCHEDULE DEPENDENCY OF ANTILEUKEMIC ACTIVITY OF PODOPHYLLOTOXIN-DERIVATIVE VP 16-213 (NSC-141540) IN L1210 LEUKEMIA
    DOMBERNOWSKY, P
    NISSEN, NI
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1973, A 81 (05): : 715 - 724
  • [46] VP-16-213 AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA WITH MONOCYTIC FEATURES
    HURD, DD
    PETERSON, BA
    MCKENNA, RW
    BLOOMFIELD, CD
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03): : 251 - 255
  • [47] REFRACTORY ACUTE LYMPHOCYTIC-LEUKEMIA - RESPONSE TO ACLACINOMYCIN-A AND VP-16-213
    ROWE, JM
    CHANG, AYC
    BENNETT, JM
    HEMATOLOGICAL ONCOLOGY, 1989, 7 (06) : 405 - 410
  • [48] PHASE-II STUDY OF VP 16-213 (ETOPOSIDE) IN REFRACTORY METASTATIC BREAST-CARCINOMA
    SCHELL, FC
    YAP, HY
    HORTOBAGYI, GN
    BUZDAR, AU
    BLUMENSCHEIN, GR
    ISSELL, B
    ESPARZA, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 357 - 357
  • [49] PENETRATION OF VP 16-213 INTO CEREBROSPINAL-FLUID AFTER HIGH-DOSE INTRAVENOUS ADMINISTRATION
    POSTMUS, PE
    HOLTHUIS, JJM
    HAAXMAREICHE, H
    MULDER, NH
    VENCKEN, LM
    VANOORT, WJ
    SLEIJFER, DT
    SLUITER, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (03) : 215 - 220
  • [50] PHARMACOKINETICS AND TOXICITY OF THE EPIPODOPHYLLOTOXIN DERIVATIVE ETOPOSIDE (VP 16-213) IN PATIENTS WITH GESTATIONAL CHORIOCARCINOMA AND MALIGNANT TERATOMA
    BRINDLEY, CJ
    ANTONIW, P
    NEWLANDS, ES
    BAGSHAWE, KD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 66 - 71
12345